Overview Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury Status: Completed Trial end date: 2013-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood mononuclear cell transplant in the treatment of chronic spinal cord injuries. Phase: Phase 1/Phase 2 Details Lead Sponsor: China Spinal Cord Injury NetworkCollaborator: Chengdu PLA General HospitalTreatments: Lithium CarbonateMethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate